SAP is now Europe’s most valuable public company
SAP has soared some 40 per cent over the last year as investors celebrated its move towards subscription-based cloud services, but the real story is the downturn in Novo’s fortunes.
Much of the damage was done in December when the stock tanked after CagriSema, Novo’s experimental anti-obesity drug, achieved a 22.7 per cent weight loss in a clinical trial, slightly below its 25 per cent target.Web Summit case: Three angry men finally settle their differences
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
SAP leapfrogs Novo Nordisk to become Europe’s most valuable companyMilestone caps a 40% rally in past year for German software group
Read more »
Novo Nordisk to explore how obesity drugs can help patients with addictionDanish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction
Read more »
Camilla Sylvest of Novo Nordisk on giving hope to people battling obesityNovo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now at least
Read more »
Generic drugmaker races to launch versions of blockbuster obesity drugsPharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year
Read more »
Bundestag to go out with a bang by debating €1 trillion stimulus planUnprecedented package for defence, climate and infrastructure spending
Read more »
German Bundestag buries Swabian housewife under €1 trillion debt pileWith an eye on Donald Trump’s Nato threats, Friedrich Merz has a plan that will permit effectively unlimited spending on defence
Read more »